E42. IS CARBOHYDRATE CONSUMPTION A RISK FACTOR IN POSTMENOPAUSAL SPINAL OSTEOPOROSIS?

Is grand multiparity a risk factor for osteoporosis in postmenopausal women of lower socioeconomic status?

OBJECTIVE We aimed to determine whether grand multiparity is a risk factor for osteoporosis among postmenopausal women of lower socioeconomic status. PATIENTS AND METHODS We conducted a single center study between February 2012 and February 2013 on 50-60 year old postmenopausal women of lower socioeconomic status without a history of medical disease. Women with a body mass index (BMI) between...

Risk Factors for Osteoporosis in Postmenopausal Women

INTRODUCTION Scientific studies show that many factors related to lifestyles affect the reduction of bone mineral density and osteoporosis in postmenopausal women. GOAL The goal of this study was to determine whether smoking, drinking coffee and alcohol in menopausal women contribute to the reduction of bone mass and osteoporosis, as well as the impact of physical activity on bone mass. MAT...

Is postmenopausal HRT a risk factor for adult-onset asthma?

Risk of infection in postmenopausal women with rheumatoid arthritis and osteoporosis taking denosumab and bDMARDS

Background: There is no clear consensus regarding the potential of denosumab for increasing the risk of infection in patients who concurrently receive biologic disease-modifying anti-rheumatic drugs (bDMARDs). In this study, we compared the rate of infection in postmenopausal women with rheumatoid arthritis who received concurrent bDMARDs and denosumab with those who received bDMARDs alone.   ...

Quantitative ultrasound and risk factor enquiry as predictors of postmenopausal osteoporosis: comparative study in primary care.

1 Lave J, Schulberg H. Integrating cost-effectiveness analyses within clinical trials of treatment for major depression in primary-care practice. In: Miller N, Magruder K, eds. Cost-effectiveness of psychotherapy: a guide for practitioners, researchers and policy makers. New York: Oxford University Press, 1999;75-84. 2 Briggs A. Economic evaluation and clinical trials: size matters. BMJ 2000;32...